Report Summary
In 2020, the global Drug Delivery in Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Delivery in Cancer development in United States, Europe and China.
The key players covered in this study
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Market segment by Type, the product can be split into
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market segment by Application, split into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players.
To present the Drug Delivery in Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Drug Delivery in Cancer are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type (2017-2027)
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein–drug Conjugates
1.4.6 Others
1.5 Market by Application
1.5.1 Global Drug Delivery in Cancer Market Share by Application (2017-2027)
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Drug Delivery in Cancer Market Size
2.2 Drug Delivery in Cancer Growth Trends by Regions
2.2.1 Drug Delivery in Cancer Market Size by Regions (2017-2027)
2.2.2 Drug Delivery in Cancer Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Drug Delivery in Cancer Market Size by Manufacturers
3.1.1 Global Drug Delivery in Cancer Revenue by Manufacturers (2017-2020)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Drug Delivery in Cancer Key Players Head office and Area Served
3.3 Key Players Drug Delivery in Cancer Product/Solution/Service
3.4 Date of Enter into Drug Delivery in Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Drug Delivery in Cancer Market Size by Type (2017-2020)
4.2 Global Drug Delivery in Cancer Market Size by Application (2017-2020)
5 United States
5.1 United States Drug Delivery in Cancer Market Size (2017-2020)
5.2 Drug Delivery in Cancer Key Players in United States
5.3 United States Drug Delivery in Cancer Market Size by Type
5.4 United States Drug Delivery in Cancer Market Size by Application
6 Europe
6.1 Europe Drug Delivery in Cancer Market Size (2017-2020)
6.2 Drug Delivery in Cancer Key Players in Europe
6.3 Europe Drug Delivery in Cancer Market Size by Type
6.4 Europe Drug Delivery in Cancer Market Size by Application
7 China
7.1 China Drug Delivery in Cancer Market Size (2017-2020)
7.2 Drug Delivery in Cancer Key Players in China
7.3 China Drug Delivery in Cancer Market Size by Type
7.4 China Drug Delivery in Cancer Market Size by Application
8 Japan
8.1 Japan Drug Delivery in Cancer Market Size (2017-2020)
8.2 Drug Delivery in Cancer Key Players in Japan
8.3 Japan Drug Delivery in Cancer Market Size by Type
8.4 Japan Drug Delivery in Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Drug Delivery in Cancer Market Size (2017-2020)
9.2 Drug Delivery in Cancer Key Players in Southeast Asia
9.3 Southeast Asia Drug Delivery in Cancer Market Size by Type
9.4 Southeast Asia Drug Delivery in Cancer Market Size by Application
10 India
10.1 India Drug Delivery in Cancer Market Size (2017-2020)
10.2 Drug Delivery in Cancer Key Players in India
10.3 India Drug Delivery in Cancer Market Size by Type
10.4 India Drug Delivery in Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Drug Delivery in Cancer Market Size (2017-2020)
11.2 Drug Delivery in Cancer Key Players in Central & South America
11.3 Central & South America Drug Delivery in Cancer Market Size by Type
11.4 Central & South America Drug Delivery in Cancer Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Delivery in Cancer Introduction
12.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2017-2020)
12.1.5 Amgen Recent Development
12.2 Teva
12.2.1 Teva Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Delivery in Cancer Introduction
12.2.4 Teva Revenue in Drug Delivery in Cancer Business (2017-2020)
12.2.5 Teva Recent Development
12.3 UCB (Union Chimique Belge)
12.3.1 UCB (Union Chimique Belge) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Delivery in Cancer Introduction
12.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2017-2020)
12.3.5 UCB (Union Chimique Belge) Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Delivery in Cancer Introduction
12.4.4 Roche Revenue in Drug Delivery in Cancer Business (2017-2020)
12.4.5 Roche Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Delivery in Cancer Introduction
12.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2017-2020)
12.5.5 Celgene Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Delivery in Cancer Introduction
12.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2017-2020)
12.6.5 Sanofi Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Delivery in Cancer Introduction
12.7.4 Merck Revenue in Drug Delivery in Cancer Business (2017-2020)
12.7.5 Merck Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Delivery in Cancer Introduction
12.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2017-2020)
12.8.5 Johnson & Johnson Recent Development
12.9 Takeda
12.9.1 Takeda Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Delivery in Cancer Introduction
12.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2017-2020)
12.9.5 Takeda Recent Development
12.10 Gilead Sciences
12.10.1 Gilead Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Delivery in Cancer Introduction
12.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2017-2020)
12.10.5 Gilead Sciences Recent Development
12.11 Pfizer
12.12 Dr Reddy
12.13 Samyang Biopharmaceuticals
12.14 Tolmar
12.15 Astellas
12.16 AMAG Pharmaceuticals
12.17 AstraZeneca
12.18 AbbVie
12.19 Novartis
12.20 Aspen
12.21 Shire (Baxalta)
12.22 Breckenridge Pharmaceuticals
12.23 Galen Pharmaceuticals
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
